Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

600 results about "Therapeutic embolization" patented technology

Embolism microsphere capable of loading platinum drugs, drug-loaded embolism microsphere and preparation method of drug-loaded embolism microsphere

The embodiment of the invention provides an embolism microsphere capable of loading platinum drugs, a drug-loaded embolism microsphere and a preparation method, and relates to the technical field of medical instruments. The structural main chain of the embolism microsphere capable of loading the platinum medicine contains adjacent carboxyl groups, and the two adjacent carboxyl groups and platinum ions in the platinum medicine can form an annular structure. The embolism microsphere provided by the embodiment of the invention can be used for efficiently loading platinum drugs.
Owner:CARDIOLINK SCI (SHENZHEN) MEDICAL TECH DEV CO LTD

Embolism microsphere capable of slowly releasing medicine and controlling degradation speed and preparation method of embolism microsphere

The invention provides an embolism microsphere capable of slowly releasing drugs and controlling degradation speed and a preparation method thereof, the method comprises the following steps: dissolving a dispersant in an oil phase liquid, and stirring at a first preset temperature to obtain a dispersion liquid; dissolving gelatin in water at a second preset temperature to obtain a gelatin solution; the preparation method comprises the following steps: dissolving a compound with negative electricity groups in water, and adding alkali liquor and an initiator in an ice bath to obtain a modified solution; adding the modified solution into a gelatin solution, stirring to obtain a water-phase pre-polymerized solution, dropwise adding the water-phase pre-polymerized solution into the dispersion solution, premixing, adding a cross-linking agent and a catalyst, and directly grafting negative electricity groups onto gelatin molecules in a low-temperature free radical polymerization manner to obtain an intermediate product; and performing post-treatment to obtain the embolism microspheres. According to the preparation method disclosed by the invention, a non-degradable material is not needed, negative electricity groups can be directly grafted on the surface of gelatin, so that the embolism microspheres have efficient drug loading performance and good long-period drug sustained release, and the degradation speed of the embolism microspheres is controlled.
Owner:HANGZHOU ALICON PHARM SCI & TEC CO LTD

Diphenylpyrazine compound as well as composition, application and preparation method thereof

ActiveCN118955410AIncrease cAMP contentImplement suppressed aggregationOrganic active ingredientsOrganic chemistryDiseaseVascular thrombosis
The invention belongs to the technical field of medical application of small molecule compounds, relates to a diphenyl pyrazine compound and a composition, application and a preparation method thereof, and mainly relates to application of the diphenyl pyrazine compound and the composition thereof in preparation of a medicine for inhibiting platelet aggregation. The invention particularly relates to application of the diphenyl pyrazine compound and the composition thereof in preparation of medicines for treating cardiovascular and cerebrovascular diseases related to platelet aggregation and other vascular thrombosis and embolic diseases. A human in-vitro platelet aggregation experiment proves that the diphenyl pyrazine compound has an extremely strong inhibition effect in the aspects of AA-induced platelet aggregation and ADP-induced platelet aggregation, and is lower in toxicity and outstanding in clinical advantage.
Owner:SHIJIAZHUANG NO 4 PHARMACEUTICAL CO LTD +1

Sugar chain marker combination for predicting prognosis of liver cancer transarterial chemoembolization and application of sugar chain marker combination

PendingCN121740815AMedical data miningMechanical/radiation/invasive therapiesTransarterial embolizationEfficacy
The invention discloses a sugar chain marker combination for predicting prognosis of liver cancer transarterial chemoembolization and application of the sugar chain marker combination. The invention discovers and verifies that the combination composed of NA3Fb, NA4Fb and NA4F2b can be used as a novel marker for evaluating TACE treatment reaction and prognosis by analyzing a serum sugar chain map of a liver cancer patient for the first time. Based on the marker combination, a TACE-GT prognosis scoring model and system are established, and the progression risk of a patient within 12 months after a TACE operation can be effectively distinguished by noninvasively detecting the expression levels of three carbohydrate chains in serum of the patient and calculating a specific score. The detection method provided by the invention is based on a blood sample, and has the advantages of noninvasiveness and convenience, and a risk assessment system can provide individualized curative effect prediction and decision support for clinicians before and after TACE treatment, and has important values for realizing precise treatment of liver cancer and improving prognosis of patients.
Owner:JIANGSU XIANSIDA BIOTECH CO LTD +1

Bending-adjustable balloon micro-catheter

The invention provides a bending-adjustable balloon micro-catheter, and belongs to the technical field of balloon micro-catheters.The bending-adjustable balloon micro-catheter comprises a catheter body, a balloon, a bending mechanism and a feedback mechanism, the catheter body is of a slender tubular structure, and an inner cavity of the catheter body is used for conveying therapeutic drugs or embolism materials or other media; the balloon is located at the far end of the catheter body, is in an ellipsoidal shape and is used for blocking blood flow or expanding blood vessels. The multiple bending mechanisms are sequentially located at the middle section position of the catheter body and are composed of shape memory alloy wires, and the shape memory alloy wires are spirally wound around the outer wall of the catheter body, connected to the catheter body and used for adjusting the bending angle and direction of the catheter body; the feedback mechanisms are pressure sensor arrays, and the number of the feedback mechanisms is eight. The problems that an existing balloon micro-catheter is difficult to accurately reach a target position in a complex blood vessel or cavity, and the blood vessel is prone to being damaged can be solved.
Owner:ANHUI MICROPOINT MEDICAL SCIENCE & TECHNOLOGY CO LTD

Preparation method of sodium hyaluronate embolism microspheres and prepared embolism microspheres

The invention relates to the technical field of medical interventional therapy materials, and particularly discloses a preparation method of sodium hyaluronate embolism microspheres and the prepared embolism microspheres. The preparation method of the sodium hyaluronate embolization microspheres comprises the following steps: S1, adding methacrylic anhydride, N, N-dimethylformamide and sodium hydroxide into a sodium hyaluronate aqueous solution, reacting, adding sodium chloride, reacting, adding absolute ethyl alcohol, precipitating, filtering to remove filtrate, cleaning and drying; s2, preparing a mixture of methacrylated sodium hyaluronate, a monomer with negative charges, an initiator and water into a water phase; a mixture of oil soluble liquid and a dispersing agent is used as an oil phase; and under the protection of nitrogen, carrying out reverse suspension polymerization. According to the preparation method of the sodium hyaluronate embolization microspheres, the methylacryloylated sodium hyaluronate and the negatively charged monomer are copolymerized to introduce the negatively charged group, so that the microspheres can effectively load chemotherapeutic drugs, and the compression elasticity is high.
Owner:SHANGHAI FANGRUN INT INSTR CO LTD

PNIPAM-based self-developing gel embolism system as well as preparation method and application thereof

The invention relates to a double-framework self-developing embolism system based on iodine modified PNIPAM gel and cross-linked albumin microspheres, which simulates a brick wall-concrete effect through a microsphere-gel composite structure and synergistically improves the embolism strength. A novel TACE treatment system is designed and constructed, multiple effects of tracing, embolism, hypoxia enhanced chemotherapy and tumor microenvironment improvement are achieved through the self-developing temperature-sensitive gel-drug carrying microspheres, and the anti-tumor effect is cooperatively improved.
Owner:SHANGHAI EIGHTH PEOPLES HOSPITAL

Multifunctional microsphere for tumor chemoradiotherapy embolism treatment and imaging as well as preparation method and application of multifunctional microsphere

The invention provides a multifunctional microsphere for tumor chemoradiotherapy embolism treatment and imaging and a preparation method and application thereof.According to the multifunctional microsphere, a polylactic acid-glycolic acid copolymer serves as a framework material, a small molecule medicine is entrapped in the multifunctional microsphere, and surface modification and radionuclide labeling are conducted at the same time; the small molecular medicine is prepared from one or more of icaritin, icariin, lecimod, imiquimod, motod, visamod and tilamod, and preferably, the icaritin and the lecimod are selected; the surface modification is performed by adopting tyramine or tyrosine polypeptide; the radionuclides include 123I, 125I, and 131 I, preferably 131 I. The preparation process and equipment of the multifunctional microsphere are simple, the cost is low, chemotherapy drugs and immunologic adjuvants are entrapped at the same time, radionuclides are marked, hepatic artery embolism treatment, 131I long-term local nuclide treatment and combined treatment of local chemotherapy and immunoregulation are achieved, and meanwhile the SPECT / CT imaging in-vivo tracing function of the multifunctional microsphere is achieved.
Owner:FUDAN UNIV SHANGHAI CANCER CENT

Implant release system and embolism interventional therapy device

The invention provides an implant release system and an embolism interventional therapy device, and relates to the field of medical instruments.The implant release system comprises a push rod and a control line, the far end of the push rod is provided with a limiting block, and the limiting block is provided with a first containing cavity and a containing groove used for containing a connecting rod; the pushing rod is further provided with a second containing cavity used for containing the release head, the second containing cavity is located on the near end side of the limiting block, an opening allowing the release head to be disengaged is formed in the radial direction of the second containing cavity, and the orientation of the opening is consistent with the orientation of the containing groove. The control line is located in the hollow cavity of the push rod, and a cushion block is arranged at the far end of the control line. The implant can be smoothly released, the structure is simple, and the release operation is convenient.
Owner:BEIJING PERCUTEK THERAPEUTICS CO LTD

Embolism hydrogel capable of achieving radiography and drug loading and moderate in degradation and preparation method of embolism hydrogel

The invention belongs to the field of medical embolism agents, and particularly relates to embolism hydrogel which can be used for radiography and drug loading and is moderate in degradation and a preparation method of the embolism hydrogel. The embolism hydrogel provided by the invention comprises two powders and two solutions, and the powders and the solutions are matched and combined with corresponding tools during use. The powder I is a multi-arm polyethylene glycol derivative with a double-bond group, the powder II is an iodine-containing contrast agent, the solution I comprises a reducing agent and an acidity regulator, and the solution II is an initiator. According to the prepared embolism agent, the problem of secondary embolism caused by the fact that the degradation time is short and the embolism effect of the embolism agent is not enough is solved, and targeted step-by-step embolism is achieved; and the double requirements of radiography and drug loading can be met at the same time.
Owner:JIANGSU MEDNOVO MEDICAL GRP CO LTD

Embolism device and conveying system thereof

The invention provides an embolism device and a conveying system thereof, and belongs to the technical field of interventional surgical instruments. The embolism device comprises embolism components, a connecting unit, a pushing component and a connection guaranteeing component, and the multiple embolism components are connected end to end; each connecting unit comprises a first buckle fixedly arranged at the near end of the corresponding embolism component and a second buckle fixedly arranged at the far end of the corresponding embolism component, and the first buckle on each embolism component can be buckled with the second buckle on the adjacent embolism component; the far end of the pushing part is detachably arranged at the near end of the embolism part, and the pushing part is used for pushing the embolism part to a target position; the connection guarantee component is used for simultaneously penetrating through the overlapped part formed after the first buckle and the second buckle are buckled so as to limit the radial displacement of the buckled first buckle and second buckle, and after the first buckle and second buckle move out of the connection guarantee component, the first buckle and second buckle are not buckled; by means of the design, the connection stability of the embolism component in the conveying process is improved, and therefore the success rate and safety of an interventional operation are remarkably improved.
Owner:SEALMED

Embolism microsphere and preparation method thereof

The invention discloses an embolism microsphere and a preparation method thereof.The embolism microsphere is prepared through the following steps that a polycarboxylate microsphere is prepared by combining a free radical polymerization method and an emulsion polymerization method, and the polycarboxylate microsphere is obtained; and saponifying and hydrolyzing the polycarboxylate microspheres to hydrolyze the polycarboxylate microspheres to obtain hydroxyl polymer microspheres, and introducing an acidic group onto the hydroxyl polymer microspheres to obtain the embolism microspheres containing both the hydroxyl group and the acidic group. The embolism microsphere disclosed by the invention realizes high loading capacity and controllable release of the anti-tumor drug, realizes accurate embolism in blood flow, and improves the treatment effect of the drug.
Owner:SHENZHEN ZHONGXIN MEDICAL TECHNOLOGY CO LTD

CT-traced tumor radiotherapy embolism microspheres and preparation method and application thereof

PendingCN119097759AAchieve combined radiotherapy and chemotherapyImprove imaging effectSurgical adhesivesX-ray constrast preparationsMeth-Polyvinyl alcohol
The invention relates to preparation and application of a tumor radiotherapy embolism microsphere preparation capable of achieving CT imaging tracing. The microsphere is prepared by taking a polyvinyl alcohol derivative as a framework material, polymerizing, cross-linking and curing the polyvinyl alcohol derivative and an N-(aminoalkyl) methacrylamide hydrochloride monomer, and further covalently connecting a metal chelating agent and a CT imaging agent 2, 3, 5-triiodobenzaldehyde. The microsphere can mark radionuclides 111ln, 68Ga, Al18F, 64Cu, 177Lu and 90Y, embolism treatment and radionuclide internal irradiation treatment are combined, meanwhile, the microsphere CT tracing function is beneficial to monitoring the distribution condition of the microsphere in real time, and ectopic embolism is reduced.
Owner:FUDAN UNIV SHANGHAI CANCER CENT

Arterial aneurysm embolization device

The invention relates to an aneurysm embolism device, which comprises an embolism main body, which comprises a near-side net body, a middle net body and a far-side net body which are sequentially connected along the axial direction of the embolism main body, and the diameter of the middle net body is smaller than the diameter of the near-side net body and the diameter of the far-side net body; the aneurysm embolism device has a compressed state and an unfolded state, in the compressed state, the near-side net body and the far-side net body are oppositely folded, the near-side net body is folded and wraps the middle net body, and the far-side net body is folded and wraps the near-side net body; therefore, the pushing resistance of the device in the conveying catheter can be reduced, and the operation difficulty is reduced.
Owner:MICROPORT NEUROTECH SHANGHAI

A kind of developing biodegradable medical polyurethane foam and preparation method thereof

The invention discloses a developing biodegradable medical polyurethane foam and a preparation method thereof, and relates to the technical field of preparation of medical embolic materials. The method comprises the following steps: mixing the developing material and isocyanate evenly, then adding polyol and catalyst, stirring evenly, then adding dispersant and water, stirring to form a stable suspension system; gradually heating up for polymerization to obtain developing polyurethane microspheres; mixing microspheres, isocyanate and part of polyol, stirring for prepolymerization, then adding the remaining polyol, catalyst, silicone oil, foaming agent and water, polymerizing and foaming the obtained mixture and heat treating, making holes, and obtaining developing biodegradable medical polyurethane foam. The foam material of the invention can be developed, blocked and degraded in minimally invasive intervention, achieving the purpose of intraoperative confirmation, postoperative tracking and prognostic diagnosis, and is suitable for cardiovascular blocking filling materials. The problem of poor performance of embolic materials in the prior art is solved.
Owner:SICHUAN UNIV

Preparation process of biodegradable embolism microspheres with blood coagulation function

The invention discloses a biodegradable embolism microsphere with a blood coagulation function, which is prepared by the following steps: by taking sodium alginate, water-soluble protein, thrombin and a water-soluble dialdehyde polysaccharide aqueous solution as a water phase and taking low-viscosity oil mixed phospholipid as an oil phase, balling through a microfluidic technology, putting the balled product into a collected liquid dissolved with calcium chloride, slowly stirring for 1-2 hours, filtering, washing and drying to obtain the biodegradable embolism microsphere with the blood coagulation function. Taking out, washing and purifying for multiple times, spraying a rapamycin solution on the surface through an atomization spraying device to realize surface drug loading, and storing in normal saline. The microspheres can achieve the effects of rapid blood coagulation and continuous blood coagulation after embolism, can provide the anti-immune effect through surface rapamycin, and can be used as an embolism agent to be applied to the field of interventional therapy of hypertrophic cardiomyopathy and other diseases.
Owner:HUNAN UNIV OF TECH

Iodine contrast agent composition

PCT designated stage expiredWO2024260346A1Hydroxy compound active ingredientsSolution deliveryVascular embolizationPharmacy medicine
Disclosed in the present application is an iodine contrast agent composition, comprising an iodine contrast agent, ethanol and water. On the basis of the volume of the pharmaceutical composition, the content of the iodine contrast agent is 208-624 mg / mL, and the content of the ethanol is 484-677 mg / mL. The composition has good effects on vascular embolization and in vivo and in vitro imaging, can meet the clinical requirements of image visualization, is clear and uniform in solution and good in stability, and has a good safety, low irritation, and little influence on tissues surrounding a focus.
Owner:CHENGDU BRILLIANT PHARMA CO LTD

Intubation fluorescent image feature learning system for hepatic artery chemoembolization

The invention relates to the technical field of medical image processing and interventional therapy assistance, and discloses an intubation fluorescent image feature learning system for hepatic artery chemoembolization. Comprising an image acquisition module which is configured to acquire a distortionless two-dimensional fluorescent blood vessel image in a hepatic artery chemoembolization super-selective intubation process; the control module is used for extracting surface geometric features of the blood vessel from the two-dimensional fluorescent blood vessel image; inputting the surface geometric features to a preset spatial reasoning model, and outputting a spatial distribution probability matrix of each blood vessel part; capturing a difference signal between the spatial distribution probability matrix and angiography feedback data in an actual intubation process in real time, and forming an iterative training data set to optimize the spatial reasoning model; and identifying a potential complex blood vessel region according to the spatial distribution probability matrix, generating an intubation path early warning signal, and generating guide parameters of X-ray release opportunity and dose based on the early warning signal so as to reduce radiation exposure.
Owner:BOCE BIOMEDICAL (TIANJIN) CO LTD

Developing embolism microsphere as well as preparation method and application thereof

The invention relates to a developing embolism microsphere as well as a preparation method and application thereof, and belongs to the technical field of embolism microspheres. The developing embolism microsphere comprises a polymer network structure formed by cross-linking polymerization of an iodine-substituted aminobenzoic acid monomer and a glycidyl ether cross-linking agent with an epoxypropane end group. The developing embolism microsphere provided by the invention has good X-ray developing capability, relatively low density, excellent suspension performance and moderate hardness and elasticity, and can be effectively applied to preparation of tumor radiotherapy, chemotherapy and embolism combined treatment medicines and developing diagnostic reagents.
Owner:CARDIOLINK SCI (SHENZHEN) MEDICAL TECH DEV CO LTD

Recombinant human microplasmin expressed by escherichia coli, production method of recombinant human microplasmin, pharmaceutical composition containing recombinant human microplasmin, kit containing recombinant human microplasmin, method for treating thromboembolism-related diseases by using recombinant human microplasmin, and application of recombinant human microplasmin

The invention provides recombinant human microplasmin (E-muPlm) expressed by escherichia coli, a production method of the recombinant human microplasmin (E-muPlm), a pharmaceutical composition and a kit containing the pharmaceutical composition. The invention also relates to applications of the pharmaceutical composition and the kit in treating thromboembolism related diseases, and a method for treating thromboembolism related diseases by using the pharmaceutical composition and the kit. The zymogen version of E-[mu] Plm or E-[mu] Plg is unstable and can be automatically activated. Furthermore, the in vivo half-life of E-[mu] Plm is significantly shorter than that of yeast-expressed microplasmin (Y-[mu] Plm), which makes the E-[mu] Plm, the pharmaceutical composition, and the kit effective in the treatment of thromboembolic diseases but reduced in bleeding side effects.
Owner:SHENZHEN BAY LAB

Infusion device for neurosurgery nursing

The invention belongs to the technical field of medical infusion, and particularly relates to a neurosurgical nursing infusion device which comprises a base, a supporting rod and a supporting plate, the base is fixedly arranged at the lower end of the supporting rod, the supporting plate is fixedly arranged at the upper end of the supporting rod, and the neurosurgical nursing infusion device further comprises a weighing hook which is arranged below the supporting plate and connected with the weighing hook. The weighing hook is used for lifting the medicine bottle; and the electromagnetic lifting mechanism is arranged at the upper end of the weighing hook. According to the invention, the RFID tag reader and the PLC are used for checking the information of medicines and patients, so that the risk of medicine use errors is reduced; a weighing sensor and an electromagnetic lifting mechanism are used for automatically adjusting the height of a medicine bottle according to liquid level changes in the medicine bottle, the infusion speed is stabilized, and the treatment effect is guaranteed; by means of the automatic speed reduction mechanism, the infusion speed is automatically reduced when liquid medicine in a medicine bottle is almost emptied, risks such as air embolism are avoided, meanwhile, an infusion tube can be heated, the infusion comfort of a patient is improved, and adverse reactions caused by low-temperature infusion are avoided.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Drug-loaded embolism microalgae ball for resisting liver cancer as well as preparation method and application of drug-loaded embolism microalgae ball

The invention discloses a drug-loaded embolism microalgae ball for resisting liver cancer and a preparation method and application thereof, and belongs to the technical field of biomedical materials, the preparation method comprises the following steps: (1) mixing microalgae cells and a drug to prepare a drug-loaded microalgae cell solution; the microalgae cells are chlorella pyrenoidosa cells or synechocystis cells; (2) taking a drug-loaded microalgae cell solution containing polyvinyl alcohol as an internal phase solution, taking a mixed solution containing polydimethylsiloxane, dimethyl silicone oil and a curing agent as an intermediate phase solution, taking a polyvinyl alcohol solution as an external phase solution, and adjusting the flow rates of the internal phase solution, the intermediate phase solution and the external phase solution by utilizing a microfluidic technology, so as to obtain a drug-loaded microalgae cell solution; and preparing to obtain the drug-loaded embolism microalgae ball for resisting liver cancer. The method disclosed by the invention is simple in process, and the prepared drug-loaded embolism microalgae balls are uniform in particle size, good in sphericity degree, excellent in biocompatibility and biodegradability and good in treatment effect on liver cancer.
Owner:THE FOURTH AFFILIATED HOSPITAL OF ZHEJIANG UNIV SCHOOL OF MEDICINE

A kind of developing embolic microsphere and preparation method thereof

A developing embolic microsphere and a preparation method thereof, belonging to the field of medical device technology. The developing embolic microsphere comprises a fluorine-containing compound, a hydroxyl-containing acrylamide monomer, a cross-linking agent containing an epoxy end group, and an ionic monomer containing a double bond, and a network structure formed by cross-linking polymerization. Among them, the fluorine-containing compound contains a silicon-oxygen bond and / or an end group with an epoxy group. The fluorine-containing compound is introduced into the embolic microsphere by chemical reaction. The fluorine-containing compound is not easy to seep out of the embolic microsphere. The fluorine-containing compound can be used as a nuclear magnetic resonance contrast agent, and has the characteristics of low toxicity and high contrast, which can make the embolic microsphere have good developing signal intensity. In addition, the fluorine-containing compound is also hydrophobic. The introduction of the fluorine-containing compound enables the embolic microsphere to have good drug loading and release properties for hydrophobic drugs.
Owner:CARDIOLINK SCI (SHENZHEN) MEDICAL TECH DEV CO LTD

Lumbricus protein peptide composition for improving vascular embolism and preparation method thereof

The invention relates to the technical field of traditional Chinese medicine health-care products, and particularly discloses an earthworm protein peptide composition for improving vascular embolism and a preparation method thereof.The earthworm protein peptide composition is prepared from, by weight, 28-34 parts of earthworm protein peptide, 20-26 parts of active pharmaceutical ingredients, 1-5 parts of ginkgo biloba extract, 12-15 parts of corn oligopeptide powder and 4-8 parts of auxiliary materials; lumbricus protein peptide, active pharmaceutical ingredients, ginkgo biloba extract and corn oligopeptide powder are used as raw materials, a solubilizing component is added in the preparation process, the solubilizing component is prepared by mixing functional extract, nattokinase and tween-80 according to a certain proportion, the functional extract is prepared by coating grape seed extract with hydroxypropyl-beta-cyclodextrin, and the solubilizing component is prepared by mixing the functional extract, the nattokinase and the tween-80 according to a certain proportion. Through the synergistic effect of the components, the antithrombotic effect of the earthworm protein peptide composition is synergistically enhanced.
Owner:SHANDONG TAIAI PEPTIDE BIOTECHNOLOGY CO LTD

Application of radix astragali seu hedysari glucoside in treatment of cerebral arterial thrombosis

The invention discloses an application of astragaloside in treatment of cerebral arterial thrombosis, belongs to the technical field of biological medicines, and observes M2 polarization of astragaloside on glial cells in cerebral arterial thrombosis and neuroinflammation regulation effects of astragaloside on the glial cells in cerebral arterial thrombosis through a PPAR gamma signal channel by utilizing a middle cerebral artery embolism rat model. It is clear that astragaloside has a neuroprotective effect on rats after cerebral arterial thrombosis, microglial cells are promoted to be transformed into M2 type by activating a PPAR gamma signal channel, and prognosis of cerebral arterial thrombosis is improved. It is proved that astragaloside has further development value in the aspect of prevention and treatment of cerebral arterial thrombosis, and the astragaloside has the prospect of becoming an ideal medicine for preventing and treating cerebral arterial thrombosis.
Owner:XINJIANG UYGUR AUTONOMOUS REGION OCCUPATIONAL DISEASE HOSPITAL (XINJIANG UYGUR AUTONOMOUS REGION OCCUPATIONAL DISEASE PREVENTION & CONTROL HOSPITAL)

Preparation system and method for gelatin embolization microspheres

A preparation system and method for gelatin embolization microspheres. The preparation system comprises a feed device, a microfluidic device, a cross-linking curing device, and a cleaning device. The feed device, the microfluidic device, the cross-linking curing device, and the cleaning device form a continuous pathway for the preparation of gelatin embolization microspheres. The preparation method comprises: formulation, feeding, microfluidic reaction, low-temperature cross-linking curing, isopropanol washing, water washing, and freeze drying. By means of said method, uniform and large-scale gelatin embolization microspheres with stable performance are obtained, thereby achieving large-scale, batch, controlled, and standardized preparation of gelatin embolization microspheres.
Owner:SICHUAN DACHUAN HEYI BIOTECHNOLOGY CO LTD

Embolic polymer, medical liquid embolic agent and its application

The present invention relates to an embolic polymer and a medical liquid embolic agent capable of long-term self-development, and belongs to the technical field of medical devices. The embolic polymer is a hydrophobic and hydrophilic iodinated block copolymer, and its phase transition speed and strength are optimized by regulating the ratio of hydrophilic and hydrophobic segments and the iodine content. After the embolic polymer is prepared into an embolic agent with a polar solvent, an in-situ solid implant is spontaneously formed through solvent exchange, which can not only realize effective embolization of the target blood vessel site, but also achieve the dual purposes of real-time development and long-term development, which is helpful for postoperative review or further treatment, and has broad application prospects.
Owner:ZHIYUAN BAIMAI (ZHEJIANG) TECHNOLOGY CO LTD

Endoluminal implant, suturing method and vascular plug system

The invention provides an intracavity implant, a suturing method and a blood vessel plug system. The intracavitary implant comprises a supporting framework, the supporting framework is of a tubular structure with an inner cavity, and the supporting framework is of a latticed structure which is formed by weaving a plurality of strands of weaving wires in a staggered mode and provided with a plurality of meshes. The inner membrane is fixed in the inner cavity of the supporting framework, the inner membrane is of a tubular structure with an inner cavity, and at least one hole is formed in the inner membrane. By means of at least one intracavity implant, plugging and treatment of a cavity can be achieved, and the intracavity implant can adapt to the form of a false cavity; the intracavitary implant provided by the invention can be expanded and formed at one time, and compared with a spring coil embolism technology, the artificial cavity can be blocked by using less materials, so that the cost is relatively low; and in addition, the forming mode is low in requirement for an operator, operation is more convenient and faster, and efficiency is higher.
Owner:HANGZHOU WEIQIANG MEDICAL TECH CO LTD